Detalhe da pesquisa
1.
mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses.
J Autoimmun
; 144: 103175, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38387105
2.
Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis.
Ann Neurol
; 93(1): 103-108, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250739
3.
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.
Allergy
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38439527
4.
Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study.
J Neurol Neurosurg Psychiatry
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729747
5.
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination.
J Neurol Neurosurg Psychiatry
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548324
6.
Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod.
Mult Scler
; 30(3): 443-447, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942812
7.
Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
Brain
; 146(11): 4562-4573, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37435933
8.
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Cochrane Database Syst Rev
; 2: CD001797, 2024 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38353301
9.
Distinct dynamics of antigen-specific induction and differentiation of different CD11c+Tbet+ B-cell subsets.
J Allergy Clin Immunol
; 152(3): 689-699.e6, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858158
10.
B-cell receptor profiling before and after IVIG monotherapy in newly diagnosed idiopathic inflammatory myopathies.
Rheumatology (Oxford)
; 62(7): 2585-2593, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36321862
11.
Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy.
J Neurol Neurosurg Psychiatry
; 2023 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879899
12.
SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(4): 280-283, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564175
13.
Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort.
J Neurol Neurosurg Psychiatry
; 95(1): 52-60, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879898
14.
The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy.
J Peripher Nerv Syst
; 28(1): 58-68, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571466
15.
Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Brain
; 145(5): 1641-1652, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139161
16.
Comprehensive overview of autoantibody isotype and subclass distribution.
J Allergy Clin Immunol
; 150(5): 999-1010, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36336400
17.
Assessment of disability in idiopathic inflammatory myopathy: a call for linearity.
Rheumatology (Oxford)
; 61(8): 3420-3426, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875011
18.
Ultrasound and MR muscle imaging in new onset idiopathic inflammatory myopathies at diagnosis and after treatment: a comparative pilot study.
Rheumatology (Oxford)
; 62(1): 300-309, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35536176
19.
Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis.
Mult Scler
; 28(1): 102-110, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33890520
20.
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post-hoc analysis of the immunoglobulin overtreatment in CIDP trial.
J Peripher Nerv Syst
; 27(2): 144-158, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507446